|Articles|December 1, 2018
Separation and Purification of a Tissue-Type Plasminogen Activator from Trichoderma reesei
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
3
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
4
How Mitigation and Maintenance Protect Against Future Risk
5
